These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 16198976

  • 1. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S.
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract] [Full Text] [Related]

  • 2. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Szarewski A.
    Lancet Oncol; 2005 Oct; 6(10):736-7; author reply 737. PubMed ID: 16198977
    [No Abstract] [Full Text] [Related]

  • 3. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
    Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer.
    Lancet Oncol; 2005 Aug; 6(8):552-3. PubMed ID: 16094770
    [No Abstract] [Full Text] [Related]

  • 4. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Aug; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptives and endometrial and cervical cancer.
    Moghissi KS.
    J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
    [No Abstract] [Full Text] [Related]

  • 6. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J.
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [Abstract] [Full Text] [Related]

  • 7. [The role of progestin in menopausal hormonal replacement therapy].
    Kauppila A.
    Duodecim; 1996 Nov; 112(12):1097-103. PubMed ID: 10593011
    [No Abstract] [Full Text] [Related]

  • 8. Combined oral contraceptives: a comprehensive review.
    Kiley J, Hammond C.
    Clin Obstet Gynecol; 2007 Dec; 50(4):868-77. PubMed ID: 17982329
    [Abstract] [Full Text] [Related]

  • 9. The pill, breast and cervical cancer, and the role of progestogens in arterial disease.
    Lincoln R.
    Fam Plann Perspect; 1984 Dec; 16(2):55-63. PubMed ID: 6373360
    [No Abstract] [Full Text] [Related]

  • 10. [Oral contraceptives: update].
    Fugère P.
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract] [Full Text] [Related]

  • 11. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC.
    J Natl Cancer Inst; 2011 Jul 06; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract] [Full Text] [Related]

  • 12. Exogenous sex hormones and risk of breast cancer.
    Smetnik V, Konovalova V.
    Gynecol Endocrinol; 2010 Mar 06; 26(3):149-51. PubMed ID: 19626508
    [No Abstract] [Full Text] [Related]

  • 13. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G.
    Ann Med; 1998 Dec 06; 30(6):511-24. PubMed ID: 9920352
    [Abstract] [Full Text] [Related]

  • 14. [HRT debate (hormone replacement therapy in menopause)].
    Lesur A, Saint-Léger S.
    Bull Cancer; 2000 Jul 06; 87(7-8):522-4. PubMed ID: 10969204
    [No Abstract] [Full Text] [Related]

  • 15. [Breast cancer and the use of hormones around menopause].
    Boukes FS, Groeneveld FP, Goudswaard AN.
    Ned Tijdschr Geneeskd; 2004 Jun 05; 148(23):1170. PubMed ID: 15211974
    [No Abstract] [Full Text] [Related]

  • 16. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
    Santen RJ, Pinkerton J, McCartney C, Petroni GR.
    J Clin Endocrinol Metab; 2001 Jan 05; 86(1):16-23. PubMed ID: 11231971
    [No Abstract] [Full Text] [Related]

  • 17. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X, Seeger H, Mueck AO.
    Minerva Endocrinol; 2012 Mar 05; 37(1):59-74. PubMed ID: 22382615
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM.
    Thromb Res; 2013 Jan 05; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [Abstract] [Full Text] [Related]

  • 19. Sex steroids and breast cancer prevention.
    Spicer DV, Pike MC.
    J Natl Cancer Inst Monogr; 1994 Jan 05; (16):139-47. PubMed ID: 7999456
    [Abstract] [Full Text] [Related]

  • 20. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP.
    Am J Obstet Gynecol; 2011 Oct 05; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.